Disease/Infection News

RSS
How human cell atlases provide the missing links between genes, diseases and therapies

How human cell atlases provide the missing links between genes, diseases and therapies

12 Dec 2022
Immunogenicity of SARS-CoV-2 antibody response in immune naïve children and adults

Immunogenicity of SARS-CoV-2 antibody response in immune naïve children and adults

12 Dec 2022
XBB Omicron variant evades vaccine-induced immunity

XBB Omicron variant evades vaccine-induced immunity

12 Dec 2022
Researchers show link between a debilitating heart condition and COVID-19 infection, vaccination

Researchers show link between a debilitating heart condition and COVID-19 infection, vaccination

12 Dec 2022
UQ-led project uses 'brain in a dish' to study effects of the Zika virus

UQ-led project uses 'brain in a dish' to study effects of the Zika virus

12 Dec 2022
What are the patterns of symptoms and risk factors for Long COVID among SARS-CoV-2 infected individuals?

What are the patterns of symptoms and risk factors for Long COVID among SARS-CoV-2 infected individuals?

12 Dec 2022
Research reveals the assembly dynamics of nucleocapsid protein condensates can be regulated by small molecules with therapeutic potential

Research reveals the assembly dynamics of nucleocapsid protein condensates can be regulated by small molecules with therapeutic potential

12 Dec 2022
Bioengineered soluble ACE2 for brain protection against SARS-CoV-2 infection

Bioengineered soluble ACE2 for brain protection against SARS-CoV-2 infection

12 Dec 2022
Forxiga (dapagliflozin) approved in Great Britain for symptomatic chronic heat failure across the full spectrum of left ventricular ejection fraction

Forxiga (dapagliflozin) approved in Great Britain for symptomatic chronic heat failure across the full spectrum of left ventricular ejection fraction

From AstraZeneca 12 Dec 2022
Quanterix’s Simoa® technology drives advances in Alzheimer’s disease research presented at 2022 Clinical Trials On Alzheimer’s Disease (CTAD) conference

Quanterix’s Simoa® technology drives advances in Alzheimer’s disease research presented at 2022 Clinical Trials On Alzheimer’s Disease (CTAD) conference

From Quanterix 12 Dec 2022
The benefit-risk of the mRNA-1273 COVID-19 vaccine

The benefit-risk of the mRNA-1273 COVID-19 vaccine

12 Dec 2022
Knowledge and attitudes to mpox among GBMSM in Australia

Knowledge and attitudes to mpox among GBMSM in Australia

12 Dec 2022
Study shows emerging Omicron sublineages efficiently evade neutralization independent of immunization history

Study shows emerging Omicron sublineages efficiently evade neutralization independent of immunization history

12 Dec 2022
Multiscale landscaping of droplet wettability and mobility of N95 masks

Multiscale landscaping of droplet wettability and mobility of N95 masks

12 Dec 2022
What is the incidence of viral rebound after treatment with nirmatrelvir-ritonavir and molnupiravir?

What is the incidence of viral rebound after treatment with nirmatrelvir-ritonavir and molnupiravir?

12 Dec 2022
ASCOT trial pinpoints most efficient level of blood thinning treatment for hospitalized COVID-19 patients

ASCOT trial pinpoints most efficient level of blood thinning treatment for hospitalized COVID-19 patients

12 Dec 2022
How the COVID-19 pandemic impacted the treatment pancreatic cancer patients

How the COVID-19 pandemic impacted the treatment pancreatic cancer patients

11 Dec 2022
Reports of Mpox disease following recent vaccination

Reports of Mpox disease following recent vaccination

11 Dec 2022
Severe COVID-19 causes aging-like changes in the human brain

Severe COVID-19 causes aging-like changes in the human brain

11 Dec 2022
Intranasal recombinant MVA-based vaccines effective against SARS-CoV-2 variants in mice

Intranasal recombinant MVA-based vaccines effective against SARS-CoV-2 variants in mice

11 Dec 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback